Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United Kingdom
/
Healthcare
/
Integrated Diagnostics Holdings
Create a narrative
Integrated Diagnostics Holdings Community
LSE:IDHC Community
3
Narratives
written by author
0
Comments
on narratives written by author
44
Fair Values set
on narratives written by author
Community Investing Ideas
Integrated Diagnostics Holdings
Popular
Undervalued
Overvalued
Integrated Diagnostics Holdings
AN
AnalystHighTarget
Community Contributor
Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery
Key Takeaways Scale improvements and easing macro pressures in key markets are driving stronger-than-expected margin expansion and greater financial flexibility for broader growth. Strategic digital, home-based, and advanced diagnostic service expansion positions the company for accelerated revenue growth and long-term leadership across targeted regions.
View narrative
US$0.91
FV
37.1% undervalued
intrinsic discount
16.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
Integrated Diagnostics Holdings
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Acquisition And Branch Expansion Will Unlock Middle East Opportunities
Key Takeaways Strategic repricing and acquisition initiatives in Saudi Arabia position IDH for increased revenue growth and margin improvements as operations scale. Expansion of new branches in Egypt and focus on radiology in Saudi Arabia poised to capture market share and boost earnings.
View narrative
US$0.68
FV
16.2% undervalued
intrinsic discount
19.89%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
19 days ago
author updated this narrative
Integrated Diagnostics Holdings
AN
AnalystLowTarget
Community Contributor
Egypt, Nigeria Risks Will Curtail Prospects Yet Saudi Will Emerge
Key Takeaways Heavy geographic concentration heightens vulnerability to local risks, while slow diversification tempers the benefits of expanding into new markets. Rising digital healthcare adoption and intensifying competition threaten core lab volumes and margin growth, challenging the long-term traditional business model.
View narrative
US$0.46
FV
25.3% overvalued
intrinsic discount
24.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative